002262.SZ
恩华药业
SZSE · Healthcare · C 制造业 · CN
CNY 21.85
−0.46%Margins
Gross margin
71.2%
EBITDA margin
23.9%
EBIT margin
20.3%
Net margin
17.9%
FCF margin
7.9%
12.8%
Return on equity
11.1%
Return on assets
14.4%
Return on invested capital
0.64x
Asset turnover
CNY 916.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026